CVS Health (CVS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Voting matters and shareholder proposals
Election of 13 directors is up for shareholder vote at the annual meeting.
Ratification of the appointment of the independent registered public accounting firm for 2025 is on the agenda.
Advisory vote on executive compensation (Say on Pay) is included.
Shareholder proposal seeks to reduce the threshold for stockholder right to act by written consent.
Proxies may vote on other business as may properly come before the meeting.
Board of directors and corporate governance
Thirteen nominees are presented for election to the board, including individuals with diverse backgrounds and expertise.
Audit committee and external auditor matters
Ratification of the independent registered public accounting firm for the 2025 fiscal year is a voting item.
Partial view of Summaries dataset, powered by Quartr API
Latest events from CVS Health
- Integrated pharmacy, PBM, and digital platforms drive consumer-focused, affordable healthcare.CVS
Leerink Global Healthcare Conference 20269 Mar 2026 - 2025 revenue and EPS exceeded expectations, but earnings hit by goodwill and litigation charges.CVS
Q4 202510 Feb 2026 - Mid-teens EPS CAGR targeted through 2028, with raised guidance and AI-native platform launch.CVS
Investor Day 20253 Feb 2026 - Q2 revenue up 2.6% to $91.2B, but EPS and guidance cut amid Health Care Benefits headwinds.CVS
Q2 20242 Feb 2026 - Revenue up 6.3% to $95.4B, but large charges drove sharp earnings decline.CVS
Q3 202416 Jan 2026 - Leadership and pricing innovations set the stage for cautious but improving financial outlooks.CVS
Wolfe Research 2024 Healthcare Conference13 Jan 2026 - 2025 guidance targets EPS growth and revenue above $385B despite ongoing cost headwinds.CVS
Q4 20248 Jan 2026 - Q1 2025 revenue up 7% to $94.6B; adjusted EPS guidance raised to $6.00–$6.20.CVS
Q1 202520 Dec 2025 - 2024 saw robust financials, leadership transitions, and enhanced pay-for-performance alignment.CVS
Proxy Filing1 Dec 2025